Skip to content

Clinical trials

Completed Triple Negative Breast Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Completed Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20102
20111
20121
20131
20164
20172
20184
20193
20202
20213
20224
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University6
Guangdong Provincial People's Hospital3
Jiangsu HengRui Medicine Co., Ltd.3
Hoffmann-La Roche2
Shanghai Junshi Bioscience Co., Ltd.2
Sun Yat-sen University2
TransThera Sciences (Nanjing), Inc.2
BeiGene1
CASI pharmaceuticals, Inc.1
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms30
Breast Neoplasms11
Biliary Tract Neoplasms1
Cholangiocarcinoma1
Gallbladder Neoplasms1
Neoplasm Metastasis1
Ovarian Neoplasms1
Prostatic Neoplasms1
Small Cell Lung Carcinoma1
Stomach Neoplasms1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.